249 related articles for article (PubMed ID: 35355655)
1. Yishen Qingli Heluo Granule in the Treatment of Chronic Kidney Disease: Network Pharmacology Analysis and Experimental Validation.
Sun X; Huang Y; Zhu S; Yan J; Gan K; Xu Z; Wang S; Kang X; Zhang J; Sun W
Drug Des Devel Ther; 2022; 16():769-787. PubMed ID: 35355655
[TBL] [Abstract][Full Text] [Related]
2. Yishen Qingli Heluo Granule Ameliorates Renal Dysfunction in 5/6 Nephrectomized Rats by Targeting Gut Microbiota and Intestinal Barrier Integrity.
Sun X; Chen J; Huang Y; Zhu S; Wang S; Xu Z; Zhang J; Sun W
Front Pharmacol; 2022; 13():858881. PubMed ID: 35814258
[TBL] [Abstract][Full Text] [Related]
3. Fufang Shenhua tablet inhibits renal fibrosis by inhibiting PI3K/AKT.
Li R; Shi C; Wei C; Wang C; Du H; Liu R; Wang X; Hong Q; Chen X
Phytomedicine; 2023 Jul; 116():154873. PubMed ID: 37257328
[TBL] [Abstract][Full Text] [Related]
4. Network Pharmacology and in vitro Experimental Verification on Intervention of Quercetin, Present in Chinese Medicine Yishen Qutong Granules, on Esophageal Cancer.
Li J; Chang JY; Jiang ZL; Yin YK; Chen JY; Jin W; Li H; Feng L
Chin J Integr Med; 2023 Mar; 29(3):233-243. PubMed ID: 36094770
[TBL] [Abstract][Full Text] [Related]
5. Exploring the Molecular Mechanism of Action of Yinchen Wuling Powder for the Treatment of Hyperlipidemia, Using Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation.
Ye J; Li L; Hu Z
Biomed Res Int; 2021; 2021():9965906. PubMed ID: 34746316
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of the Bupi Yishen formula on renal fibrosis through PI3K/AKT signaling inhibition.
Liu B; Deng J; Jie X; Lu F; Liu X; Zhang D
J Ethnopharmacol; 2022 Jul; 293():115242. PubMed ID: 35367329
[TBL] [Abstract][Full Text] [Related]
7. Uncovering Bupi Yishen Formula Pharmacological Mechanisms Against Chronic Kidney Disease by Network Pharmacology and Experimental Validation.
Zhang D; Liu B; Jie X; Deng J; Lu Z; Lu F; Liu X
Front Pharmacol; 2021; 12():761572. PubMed ID: 34867380
[TBL] [Abstract][Full Text] [Related]
8. Network Pharmacology-Based and Molecular Docking-Based Analysis of Suanzaoren Decoction for the Treatment of Parkinson's Disease with Sleep Disorder.
Liu YY; Yu LH; Zhang J; Xie DJ; Zhang XX; Yu JM
Biomed Res Int; 2021; 2021():1752570. PubMed ID: 34660782
[TBL] [Abstract][Full Text] [Related]
9. Xiao-Luo-Wan treats propylthiouracil-induced goiter with hypothyroidism in rats through the PI3K-AKT/RAS pathways based on UPLC/MS and network pharmacology.
Dong S; Liu Q; Jiang M; Ma Q; Huang Q; Liu T; Li Y; Ni L; Shi Y
J Ethnopharmacol; 2022 May; 289():115045. PubMed ID: 35101570
[TBL] [Abstract][Full Text] [Related]
10. Prediction of the mechanisms of action of Shenkang in chronic kidney disease: A network pharmacology study and experimental validation.
Qin T; Wu L; Hua Q; Song Z; Pan Y; Liu T
J Ethnopharmacol; 2020 Jan; 246():112128. PubMed ID: 31386888
[TBL] [Abstract][Full Text] [Related]
11. Study on Medication Rules of Traditional Chinese Medicine in Treating Constipation through Data Mining and Network Pharmacology.
Xu SM; Bai LP; Lu JG; Dong QJ; Cao B
Biomed Res Int; 2022; 2022():6733851. PubMed ID: 36267846
[TBL] [Abstract][Full Text] [Related]
12. A Network Pharmacology Approach to Explore the Mechanism of HuangZhi YiShen Capsule for Treatment of Diabetic Kidney Disease.
Zhou XF; Zhou WE; Liu WJ; Luo MJ; Wu XQ; Wang Y; Liu P; Wen YM; Li JL; Zhao TT; Zhang HJ; Zhao HL; Li P
J Transl Int Med; 2021 Jun; 9(2):98-113. PubMed ID: 34497749
[TBL] [Abstract][Full Text] [Related]
13. [Therapeutic mechanism of Shenbing Decoction Ⅲ for renal fibrosis in chronic kidney disease: a study with network pharmacology, molecular docking and validation in rats].
Luo G; Liu H; Xie B; Deng Y; Xie P; Zhao X; Sun X
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Jun; 43(6):924-934. PubMed ID: 37439164
[TBL] [Abstract][Full Text] [Related]
14. Potential Molecular Mechanism of Yishen Capsule in the Treatment of Diabetic Nephropathy Based on Network Pharmacology and Molecular Docking.
Hu Y; Liu S; Liu W; Zhang Z; Liu Y; Li S; Sun D; Zhang G; Fang J
Diabetes Metab Syndr Obes; 2022; 15():943-962. PubMed ID: 35378831
[TBL] [Abstract][Full Text] [Related]
15. GC-MS and Network Pharmacology Analysis of the Ayurvedic Fermented Medicine, Chandanasava, Against Chronic Kidney and Cardiovascular Diseases.
Vinothkanna A; Prathiviraj R; Sivakumar TR; Ma Y; Sekar S
Appl Biochem Biotechnol; 2023 May; 195(5):2803-2828. PubMed ID: 36418713
[TBL] [Abstract][Full Text] [Related]
16. [Mechanism of Danggui Sini Decoction in treatment of primary dysmenorrhea based on network pharmacology and molecular docking].
Que DH; Chen WH; Jiang FP; Pan F; Yang K
Zhongguo Zhong Yao Za Zhi; 2021 Feb; 46(4):855-864. PubMed ID: 33645090
[TBL] [Abstract][Full Text] [Related]
17. A network pharmacology approach to determine the underlying mechanisms of action of Yishen Tongluo formula for the treatment of oligoasthenozoospermia.
Chen Y; Bi F; Sun Z
PLoS One; 2021; 16(6):e0252906. PubMed ID: 34153045
[TBL] [Abstract][Full Text] [Related]
18. Systematic Evaluation of the Mechanisms of Mulberry Leaf (Morus alba Linne) Acting on Diabetes Based on Network Pharmacology and Molecular Docking.
Wu Q; Hu Y
Comb Chem High Throughput Screen; 2021; 24(5):668-682. PubMed ID: 32928080
[TBL] [Abstract][Full Text] [Related]
19. A network pharmacology approach to explore active compounds and pharmacological mechanisms of a patented Chinese herbal medicine in the treatment of endometriosis.
Wu Y; Zhu Y; Xie N; Wang H; Wang F; Zhou J; Qu F
PLoS One; 2022; 17(2):e0263614. PubMed ID: 35130311
[TBL] [Abstract][Full Text] [Related]
20. [Identification of traditional Chinese drugs containing active ingredients for treating myocardial infarction and analysis of their therapeutic mechanisms by network pharmacology and molecular docking].
Zhao S; Liu K; Duan J; Tao X; Li W; Bai Y; Wei P; Xi M; Yang H
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Jan; 42(1):13-25. PubMed ID: 35249866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
